Craig Johnson - 31 Jan 2025 Form 4/A - Amendment Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/Kathryn Lester Attorney-in-fact for Craig A. Johnson
Issuer symbol
HRTX
Transactions as of
31 Jan 2025
Transactions value $
$0
Form type
4/A - Amendment
Filing time
04 Feb 2025, 17:30:25 UTC
Date Of Original Report
03 Feb 2025
Previous filing
03 Feb 2025
Next filing
16 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award $0 +18K +27.27% $0.00 83.8K 31 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Stock Option (Right to Buy) Award $0 +35.9K $0.00 35.9K 31 Jan 2025 Common Stock 35.9K $1.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in full on January 31, 2026. Each restricted stock unit represents a contigent right to receive one share of common stock.
F2 The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.